R Squared’s MIRA Pharmaceuticals MIRA Stock Holding History

R Squared’s Portfolio MIRA Stock Details MIRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-160	Closed	-$182	–	1001
2024 Q4	$182	Buy	+160	New	+$209	﹤0.01%	1559

Other funds holding MIRA

CSI

Cross Staff Investments Pittsford, New York $197M AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SEM

Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JWCA

J.W. Cole Advisors Tampa, Florida $2.96B AUM 23.14% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

FAB

First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return

PWM

Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return

R Squared's MIRA Position: Q1 2025 in Review

R Squared sold out of MIRA Pharmaceuticals (MIRA) in Q1 2025, closing a stake of 160 shares — an estimated $182 sold.

R Squared first reported a position in MIRA in Q4 2024 and held it in 1 quarter. The position peaked at $182 in Q4 2024. 19 funds tracked by Wall St. Rank hold MIRA as of Q1 2025.

R Squared reported no remaining MIRA Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
R Squared sold 160 MIRA Pharmaceuticals shares in Q1 2025, an estimated $182.
R Squared first reported a position in MIRA Pharmaceuticals in Q4 2024 and held it in 1 quarter.
R Squared's MIRA Pharmaceuticals position peaked at $182 in Q4 2024.
19 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.